Core Viewpoint - The 2025 CAME (China Aroma and Cosmetic Industry Annual Conference and Expo) held in Nanjing focused on "Technology, Brand, and Co-prosperity," showcasing over 500 brands and more than 1,000 new products, emphasizing the integration of government, industry, academia, research, and investment [2][5][38]. Group 1: Event Overview - The event featured high-quality, high-standard, and professional exhibitions, attracting leading beauty companies such as L'Oréal, Procter & Gamble, and Unilever, along with top raw material suppliers like BASF and DSM, creating an "all-star" lineup [5][10]. - CAME has evolved into a "core technology release conference" for domestic and international beauty brands and raw material companies, highlighting its significance in the industry [8][10]. Group 2: Technological Innovations - Numerous innovative technological achievements were showcased, with a strong emphasis on "Chinese-style innovation," including Proya's mitochondrial anti-aging technology and Shiseido's research on the hidden skincare benefits of fermented natto bacteria [10][11][17]. - Shanghai Jahwa introduced the industry's first non-invasive skin glycation quantification and imaging device, filling a gap in the cosmetic field [12]. Group 3: Industry Trends - The event highlighted a shift in the cosmetics industry from "scale expansion" to "value enhancement," with raw material innovation becoming a strategic pivot for this transformation [23][38]. - The demand for diverse consumer needs is pushing upstream supply chain companies to continuously innovate in technology research and scientific communication [23][26]. Group 4: Collaboration and Future Outlook - CAME serves as a bridge for collaboration among raw material suppliers, brands, distributors, and technology companies, accelerating technology transfer and commercial cooperation [34][37]. - The conference is viewed as a crucial opportunity for enhancing the global competitiveness of domestic brands, with a focus on high-quality innovation and development [38].

Core Insights - The global beauty industry is projected to exceed $677 billion by 2025, indicating strong growth, while the Chinese cosmetics market is undergoing significant structural changes, moving away from reliance on single blockbuster products or marketing gimmicks to a focus on genuine brand strength [1][2]. Market Performance - The Chinese cosmetics retail market is expected to maintain moderate growth in the first half of 2025, with retail sales reaching 2.291 billion yuan, a year-on-year increase of 2.9%, although this is below the overall retail growth rate of 5.0% [2][4]. - International beauty giants are facing pressure in the Chinese market, with L'Oréal leading with sales of 186.19 billion yuan, a 3% increase year-on-year, while Estée Lauder reported a 10.88% decline in net sales, marking its lowest sales in five years [4][6]. Domestic Brand Performance - Domestic brands are showing resilience, with the retail scale of the Chinese cosmetics market reaching 1.0738 trillion yuan in 2024, and domestic brands capturing 55.2% of the market share [6][8]. - The top ten domestic beauty companies reported a total revenue growth of 11.72% in the first half of 2025, with Proya, Shiseido, and Shanghai Jahwa leading the rankings [7][8]. Consumer Trends - The beauty market is witnessing a shift towards rational consumption, with consumers increasingly sensitive to price and favoring cost-effective products. The sales of beauty and skincare products reached 235.23 billion yuan in the first half of 2025, a 10.1% increase year-on-year [12][13]. - The anti-aging market is experiencing significant growth, with total sales reaching 65.49 billion yuan, a 30.3% increase year-on-year, and the demand for anti-aging products is expanding to younger demographics [13][14]. Brand Strategies - Brands are increasingly adopting multi-brand strategies to address diverse consumer needs, moving from a single product focus to a more comprehensive brand matrix [14][19]. - Investment in research and development is on the rise among leading domestic brands, with a focus on building technological barriers and enhancing product efficacy [15][16]. Marketing and Distribution - Douyin (TikTok) has solidified its position as a growth engine for the beauty industry, with daily views of beauty videos exceeding 2.5 billion, reflecting a shift towards more refined and systematic marketing strategies [17][18]. - The competition is evolving from a focus on single-channel strategies to an integrated approach that balances online and offline resources, emphasizing the importance of brand experience and customer loyalty [18][19].

东方证券研报指出，作为IFSCC金级战略合作伙伴，珀莱雅日前携14项科研成果重磅亮相，更凭借一项 具有突破意义的线粒体抗衰研究，成功摘得" IFSCC2025 十大基础研究奖"，成为本年度唯一获此奖项 的中国化妆品企业，也是至今中国企业在世界化妆品比赛中取得的最好成绩。近期公司对外投资的节奏 有所加快，未来全球化投资布局将成为公司迈向行业巨头的重要抓手。该行认为公司目前走在正确的战 略道路上，而目前市场估值建立在短期经营的悲观假设之上，因此该行提示对公司的左侧布局机会。无 论是新管理团队的组建，还是研发的持续投入、对外投资的加快还是H股的启动，认为公司经营都走在 正确的战略轨道中，对公司中期保持可持续较快增长抱有信心。对公司维持2025-2027 年每股收益分别 为4.44、5.13 和5.88元的预测， DCF目标估值116.85元，维持"买入"评级。 ...

| 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 113634 | 珀莱转债 | 可转债转股停 | 2025/10/10 | | | | | | | 牌 | | | | | | 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2025-058 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 实施 2025 年半年度权益分派时"珀莱转债"停止转股 的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施 2025 年半年度权益分派,珀莱雅化妆品股份有限公司（以下简称"公司"） 的相关证券停复牌情况如下： 1、公司将于 2025 年 10 月 13 日在《上海证券报》、《证券时报》、《中国证券 报》、《证券日报》、《经济参考报》、《中国日报》 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the strong performance of the retail and beauty sectors, with a focus on the growth potential of domestic brands in the beauty industry [6][44] - The medical beauty segment is expected to see new growth drivers from innovative products, while the cosmetics sector is benefiting from the rise of domestic brands and consumer trends towards self-care [6][44] Summary by Sections 1. Market Review - The beauty and personal care index rose by 6.84% in August 2025, ranking 15th among all primary industries, underperforming the broader market which saw a 7.97% increase [12][15] - In the medical beauty sector, notable stock performances in August included Meili Tianyuan Medical Health (+32.4%), Kedi (+31.7%), and Yisi Health (+22.7%) [16] - In the cosmetics sector, leading performers were Jiaheng Home (+55.4%), Shuiyang Co. (+36.3%), and Ruoyu Chen (+29.0%) [20] 2. Medical Beauty - Jinbo Biological's "Recombinant Type III Humanized Collagen Freeze-Dried Fiber" received drug auxiliary material registration, marking a significant advancement in the medical field [26] - Longzi Co. plans to acquire 67.5% of Chongqing Milan Baiyu for 92.475 million yuan, with performance commitments ensuring net profits of at least 9.29 million yuan, 9.89 million yuan, and 11.83 million yuan from 2025 to 2027 [28] 3. Cosmetics - Proya plans to list in Hong Kong, potentially becoming the first A+H share beauty company, which would enhance its international business development [32] - Proya's investment in Huazhi Xiao will strengthen its position in the makeup sector, leveraging Huazhi Xiao's content operations and overseas channels [35] - The launch of the NAN beauty brand by Shangmei Co. represents a strategic move to enhance its presence in the mid-to-high-end market [40] 4. Investment Recommendations - The report recommends focusing on leading domestic beauty brands that are continuously evolving and capitalizing on high-growth segments [44] - Key recommendations include Shangmei Co., Maogeping, Proya, and Runben Co., with an emphasis on their strong market positions and growth potential [48]

美妆行业 周度市场观察 行业环境 头部品牌动态 投资运营 产品技术 营销活动 2025/9.15-9.21 第 39 周 01 行业趋势 Industry Trends 本周看点： 27个高端香氛品牌拓店盘点，谁是当之无愧的"香"饽饽？ 国货美妆十强：谁掉队，谁逆袭？ 国货美妆下半场：科学驱动、场景细分与全球化。 行业环境： 1. 抖音电商让「中国好成分」被重新看见 关键词：中国好成分,护肤需求,美白淡斑,控油祛痘,抗老紧致 概要：抖音电商推出「中国好成分」主题活动，联合林清轩、薇诺娜等10余家国货护肤品牌， 溯源安徽灵芝、云南青刺果等天然成分，展现其东方智慧与现代科技融合的价值。活动邀请皮 肤科专家解读成分功效，绘制「肌肤地图」，并通过溯源直播、达人种草、专场店播等形式， 提升消费者对国货成分的认知与信任。内容场与货架场联动，打造从知识分享到购买的闭环， 推动国货美妆科学升级，彰显中国护肤品的自主创新与大国自信。 原文链接：https://socialbeta.com/campaign/26024 2. 27个高端香氛品牌拓店盘点，谁是当之无愧的"香"饽饽？ 关键词：香氛品类,逆势上扬,市场规模,消费者认知 ...

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 116.85 CNY [3][4][10] Core Views - The company is expected to achieve earnings per share of 4.44, 5.13, and 5.88 CNY for the years 2025, 2026, and 2027 respectively, indicating a positive growth trajectory [3][10] - The report highlights the importance of ongoing research and development, which has been recognized at international levels, as a key driver for sustainable growth in the competitive cosmetics industry [9] - Recent investments, including a significant stake in a domestic makeup brand, are seen as strategic moves to enhance market insights and expand the company's ecosystem [9] - The report suggests that the company's current market valuation is based on overly pessimistic short-term assumptions, presenting an opportunity for left-side positioning [9] Financial Summary - Projected revenue growth from 8,905 million CNY in 2023 to 14,156 million CNY in 2027, with a compound annual growth rate (CAGR) of approximately 9.5% [3][12] - Operating profit is expected to increase from 1,503 million CNY in 2023 to 2,837 million CNY in 2027, reflecting a strong growth rate [3][12] - Net profit attributable to the parent company is forecasted to grow from 1,194 million CNY in 2023 to 2,330 million CNY in 2027, with a notable increase in net profit margin from 13.4% to 16.5% [3][12] - The company’s gross margin is projected to improve from 69.9% in 2023 to 73.6% in 2027, indicating enhanced operational efficiency [3][12]

Group 1 - The cosmetics sector experienced a slight increase of 0.1% on September 26, with Qingdao King leading the gains [1] - The Shanghai Composite Index closed at 3828.11, down 0.65%, while the Shenzhen Component Index closed at 13209.0, down 1.76% [1] - Key stocks in the cosmetics sector showed varied performance, with Qingdao King rising by 3.49% to a closing price of 8.00 [1] Group 2 - The cosmetics sector saw a net inflow of 55.80 million yuan from main funds, while retail investors experienced a net outflow of 30.36 million yuan [2] - Major stocks like Qingdao King and Shanghai Jahwa had significant net inflows from main funds, indicating investor interest [3] - The overall trading volume and turnover in the cosmetics sector reflected active market participation, with Qingdao King achieving a turnover of 3.83 billion yuan [1][2]

Summary of the Medical Aesthetics and Cosmetics Industry Conference Call Industry Overview - The medical aesthetics industry in China has a significantly lower penetration rate compared to the US and South Korea, indicating substantial growth potential. The current penetration rate is approximately 2 per 1,000 people, while the US and South Korea have rates of 5‰ and 8‰ respectively, suggesting a large market opportunity for growth [2][3][4] - The consumer repurchase rate for medical aesthetics is high, with stable demand for light medical aesthetics services, which provides a solid foundation for industry development [2][3] Market Dynamics - The medical aesthetics industry is divided into two main segments: medical aesthetics and cosmetics. The medical aesthetics segment remains robust post-pandemic, with a focus on product and material development [3][4] - The upstream raw material sector has high gross margins, with companies like Aimeike achieving margins of 85%-90%. The typical markup at the consumer level is over three times the factory price, ensuring profitability for institutions and sales personnel [2][4] Capital Market Trends - Capital markets are increasingly focused on upstream manufacturers, particularly the transition from hyaluronic acid to active materials such as recombinant collagen and PDRN. This shift is driven by rising consumer demand for facial treatments [7] - The market for light medical aesthetics accounts for approximately 70% in leading hospitals, with new medical aesthetics primarily divided into photonic and injection categories [8] Product Market Size - The market size for hyaluronic acid and botulinum toxin at the factory level is estimated to be between 50 to 100 billion yuan. The markup for mature products typically ranges from 2 to 3 times, with high-end products potentially reaching 3 to 4 times [9] - The regenerative materials market has seen rapid growth, with several companies achieving sales exceeding 1 billion yuan since 2021. However, these materials are not fully replacing hyaluronic acid but rather expanding the market [10][11] Material Development and Trends - The development of regenerative materials is significant, with a focus on micro-spheres that stimulate natural repair and collagen regeneration. These materials are expected to enhance treatment effectiveness and safety in soft tissue filling and skin management [15][16] - The future of the medical aesthetics industry is expected to shift towards active micro-spheres and humanized collagen, with a focus on extracellular matrix and various collagen types [15] Cosmetics Industry Overview - The cosmetics industry has seen a clear trend towards domestic brand replacement, with domestic brands now accounting for over 50% of the market. Brands are leveraging e-commerce and live streaming to enhance growth, with increased R&D investments focusing on efficacy and ingredient-driven strategies [2][21] - The market has shifted from high-end luxury products to a broader consumer base, with skincare products maintaining steady growth despite the pandemic [21][22] Sales Dynamics - The sales of domestic cosmetics exhibit seasonal variations, with the first half of the year accounting for about 40% of total sales and the second half for 60%. Major shopping events like 618 and Double Eleven significantly impact annual sales [24] R&D Investment Differences - There is a notable difference in R&D investment between the medical aesthetics and cosmetics industries. The medical aesthetics sector focuses on material iteration, while the cosmetics industry emphasizes brand building and marketing to enhance consumer loyalty [25] Future Outlook - The future of domestic cosmetics companies appears optimistic, with expectations of revenue growth driven by channel changes and ingredient innovations. Companies like Perfect Diary and Proya are projected to reach revenue levels of 20 to 30 billion yuan in the next 3 to 5 years [30]

Investment Rating - The report maintains a "Positive" outlook on the beauty and personal care industry, highlighting the resilience of domestic brands and the impact of new consumption trends [2]. Core Insights - The beauty and personal care sector experienced a robust recovery in H1 2025, with a retail sales growth of 2.9%, reversing the previous decline due to favorable consumption policies and improved income expectations [5][6]. - Domestic brands are gaining market share, with top local brands now competing closely with international counterparts, indicating a significant shift in consumer preferences [10][11]. - The report categorizes companies into three groups based on performance: those with strong brand matrices benefiting from multi-brand strategies, those capitalizing on consumer trends like domestic brands and collagen products, and those showing signs of strategic improvement [20][23]. Summary by Sections Industry Overview - The beauty market is projected to grow steadily, with a forecasted retail sales decline of 1.1% in 2024, followed by a recovery in H2 2025 [5][6]. - The domestic market share is expected to increase, with local brands achieving significant breakthroughs in both skincare and makeup segments [10][11]. Company Performance - **Cosmetics Sector**: - Major companies like Up Beauty and Proya reported revenue growth of 17.3% and 7.2% respectively in H1 2025, with net profits increasing by 30.6% and 13.8% [20][21]. - Other notable performers include Marubi and Water Sheep, with revenue growth of 30.8% and 9.0% respectively [21][22]. - **Personal Care Sector**: - Companies like Ruibin and Zhenjia showed remarkable growth, with Ruibin's revenue increasing by 67.6% and Zhenjia's by 157.11% in H1 2025 [5][20]. - **Medical Aesthetics Sector**: - Companies like Aimeike and Langzi reported mixed results, with Aimeike's revenue declining by 21.6% while Langzi's net profit surged by 64.1% [20][24]. Investment Recommendations - The report recommends investing in companies with strong brand matrices and low PE multiples, such as Up Beauty and Proya, as well as those benefiting from the Douyin traffic boost like Marubi and Water Sheep [20][24]. - It also suggests focusing on high-value segments and innovative products from brands like Ruibin and Furuida, and highlights opportunities in the maternal and infant sector with companies like Shengbeila and Haiziwang [20][24].